[{"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-001", "question": "A 74-year-old man presents with heart failure with preserved ejection fraction (HFpEF) and bilateral carpal tunnel syndrome. Echocardiography reveals a granular 'sparkling' appearance of the myocardium and increased wall thickness. A technetium-99m pyrophosphate (PYP) scan shows Grade 3 cardiac uptake (uptake > rib uptake). Serum immunofixation reveals a small IgG lambda monoclonal protein, and serum free light chain ratio is 1.8. Which of the following is the most appropriate next step in management to confirm the diagnosis?", "options": ["Initiate tafamidis therapy", "Perform TTR genetic testing", "Endomyocardial biopsy", "Abdominal fat pad aspiration", "Initiate bortezomib, cyclophosphamide, and dexamethasone"], "answer": "C", "answer_index": 2, "explanation": "While Grade 2/3 PYP uptake is highly specific for ATTR cardiac amyloidosis, this specificity drops significantly in the presence of a monoclonal gammopathy (MGUS). AL amyloidosis can occasionally show uptake on PYP scans. Therefore, in a patient with a positive PYP scan AND a monoclonal protein, a tissue biopsy (endomyocardial is gold standard if non-cardiac biopsy is negative or to avoid sampling error) is mandatory to distinguish ATTR from AL amyloidosis before starting treatment.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To determine the best next step in management for this patient, I need to analyze the clinical presentation and diagnostic findings.\n\nThe patient presents with:\n- HFpEF (heart failure with preserved ejection fraction)\n- Bilateral carpal tunnel syndrome\n- Echocardiography showing \"sparkling\" appearance and increased wall thickness\n- Grade 3 cardiac uptake on PYP scan (uptake > rib uptake)\n- Small IgG lambda monoclonal protein\n- Serum free light chain ratio of 1.8 (slightly abnormal)\n\nThese findings strongly suggest cardiac amyloidosis. The PYP scan with Grade 3 uptake is highly specific for transthyretin (TTR) amyloidosis rather than light chain (AL) amyloidosis. The presence of carpal tunnel syndrome is also common in TTR amyloidosis.\n\nHowever, the presence of a monoclonal protein and abnormal free light chain ratio raises the possibility of AL amyloidosis as well, which would require different treatment.\n\nBefore initiating treatment (options A or E), the exact type of amyloidosis must be confirmed. While the PYP scan suggests TTR amyloidosis, the monoclonal protein finding creates diagnostic uncertainty.\n\nGenetic testing (option B) would only determine if TTR amyloidosis is hereditary or wild-type, but wouldn't confirm the diagnosis given the ambiguous findings.\n\nAbdominal fat pad aspiration (option D) can detect amyloid deposits but has limited sensitivity and may not differentiate between types.\n\nEndomyocardial biopsy (option C) remains the gold standard for definitively diagnosing cardiac amyloidosis and determining the specific type through immunohistochemistry or mass spectrometry.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-002", "question": "A 24-year-old male presents with recurrent fevers, livedo racemosa, and acute left hemiparesis. MRI shows a lacunar infarct in the internal capsule. Angiography reveals a 'beads-on-a-string' appearance in the mesenteric and renal arteries. Laboratory evaluation shows low serum IgM and IgG levels. Genetic testing confirms a biallelic loss-of-function mutation in ADA2. Which of the following is the most appropriate maintenance therapy?", "options": ["Cyclophosphamide", "Rituximab", "Etanercept", "Prednisone monotherapy", "Plasma exchange"], "answer": "C", "answer_index": 2, "explanation": "The patient has Deficiency of Adenosine Deaminase 2 (DADA2), which mimics Polyarteritis Nodosa (PAN) but is distinct due to its association with early-onset strokes and hypogammaglobulinemia. Unlike classic PAN, which is treated with cyclophosphamide, DADA2 is driven by TNF-alpha dysregulation. TNF inhibitors (like etanercept) are the treatment of choice and are highly effective in preventing recurrent strokes, whereas cyclophosphamide is often ineffective.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To answer this question, I need to analyze the clinical presentation and diagnosis.\n\nThe patient has:\n- Recurrent fevers\n- Livedo racemosa (skin finding)\n- Acute hemiparesis with lacunar infarct\n- \"Beads-on-a-string\" appearance on angiography (suggestive of vasculitis)\n- Low immunoglobulin levels\n- Confirmed biallelic mutation in ADA2\n\nThis is a case of Deficiency of Adenosine Deaminase 2 (DADA2), a rare autoinflammatory disease characterized by vasculopathy, strokes, and immunodeficiency.\n\nFor maintenance therapy in DADA2:\n- Cyclophosphamide: Used in some vasculitides but not first-line for DADA2\n- Rituximab: Targets B cells but not specifically indicated for DADA2\n- Etanercept: A TNF-alpha inhibitor, which is the standard of care for DADA2\n- Prednisone monotherapy: May help symptoms but doesn't prevent progression\n- Plasma exchange: Used for acute management, not maintenance therapy\n\nTNF inhibitors like etanercept are the mainstay of treatment for DADA2, as the disease involves TNF-alpha-mediated inflammation.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-003", "question": "A 64-year-old male presents with a 1-year history of progressive gait instability, dysarthria, and dysphagia. His wife reports he has severe insomnia, stridor during sleep, and acts out his dreams. Polysomnography confirms obstructive sleep apnea and complex behaviors during both REM and NREM sleep. MRI brain is unremarkable. Which of the following antibodies is most likely to be positive?", "options": ["Anti-Hu", "Anti-Ma2", "Anti-LGI1", "Anti-IgLON5", "Anti-DPPX"], "answer": "D", "answer_index": 3, "explanation": "Anti-IgLON5 disease is a distinct tauopathy characterized by a unique sleep disorder (parasomnias in both REM and NREM sleep, stridor, OSA) combined with bulbar dysfunction and gait instability. While Anti-Ma2 is associated with brainstem/diencephalic involvement and sleepiness, the specific combination of stridor, NREM parasomnias, and bulbar palsy is pathognomonic for Anti-IgLON5.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "D", "model_outputs": "I need to analyze this patient's presentation to determine the most likely antibody.\n\nKey clinical features:\n- 64-year-old male\n- Progressive gait instability, dysarthria, and dysphagia (bulbar symptoms)\n- Severe insomnia\n- Stridor during sleep\n- Acting out dreams (REM sleep behavior disorder)\n- Polysomnography showing complex behaviors during both REM and NREM sleep\n- Unremarkable brain MRI\n\nThis presentation is highly characteristic of anti-IgLON5 disease, which is an autoimmune disorder associated with:\n- Progressive bulbar symptoms (dysarthria, dysphagia)\n- Sleep disorders including complex behaviors during both REM and NREM sleep\n- Stridor\n- Normal brain imaging\n- REM sleep behavior disorder\n\nAnti-Hu is typically associated with paraneoplastic encephalomyelitis and sensory neuropathy.\nAnti-Ma2 is associated with limbic, diencephalic, or brainstem encephalitis.\nAnti-LGI1 typically causes limbic encephalitis with seizures and memory impairment.\nAnti-DPPX is associated with gastrointestinal symptoms, central hyperexcitability, and encephalitis.\n\nThe answer is (D)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-004", "question": "A 68-year-old male presents with fever of unknown origin, 15 kg weight loss, and fatigue 4 years after undergoing aortic valve replacement. Labs reveal pancytopenia and elevated liver enzymes. TTE and TEE show no vegetations. PET-CT demonstrates hypermetabolic activity in the spleen and bone marrow. Bone marrow biopsy reveals non-caseating granulomas. Standard blood cultures are negative. Which of the following is the most likely etiology?", "options": ["Sarcoidosis", "Culture-negative endocarditis (HACEK group)", "Mycobacterium chimaera", "Tropheryma whipplei", "Late-onset prosthetic valve thrombosis"], "answer": "C", "answer_index": 2, "explanation": "This is the classic presentation of disseminated *Mycobacterium chimaera* infection associated with contaminated heater-cooler units used during cardiopulmonary bypass. The incubation period can be several years. It presents with systemic symptoms, cytopenias, and granulomatous inflammation (often misdiagnosed as sarcoidosis). Diagnosis requires specific mycobacterial blood cultures or tissue PCR.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To determine the most likely etiology, I'll analyze the key clinical features of this case:\n\n1) 68-year-old male with fever of unknown origin, weight loss, fatigue\n2) History of aortic valve replacement 4 years ago\n3) Pancytopenia and elevated liver enzymes\n4) No vegetations on cardiac imaging\n5) Hypermetabolic activity in spleen and bone marrow on PET-CT\n6) Non-caseating granulomas on bone marrow biopsy\n7) Negative standard blood cultures\n\nAnalyzing each option:\n\nA. Sarcoidosis - Can present with non-caseating granulomas, but the timing after valve surgery is suspicious for an infection-related complication.\n\nB. Culture-negative endocarditis (HACEK) - Would typically show vegetations on TEE and doesn't commonly cause granulomas.\n\nC. Mycobacterium chimaera - Associated with cardiac surgery, particularly valve replacement, with delayed presentation (years later). Causes disseminated infection with granulomas, pancytopenia, and hepatitis. Standard blood cultures would be negative.\n\nD. Tropheryma whipplei - Can cause culture-negative endocarditis but typically presents with GI symptoms and arthralgia.\n\nE. Prosthetic valve thrombosis - Would not explain granulomas, pancytopenia, or the systemic inflammatory picture.\n\nMycobacterium chimaera infection is strongly associated with heater-cooler devices used during cardiac surgery, with a latency period of several years, and presents with this exact constellation of findings.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-005", "question": "A 31-year-old female presents with amenorrhea 4 months after a full-term delivery. Ultrasound reveals a 4 cm echogenic mass in the myometrium. Serum beta-hCG is 120 IU/L. Immunohistochemistry of a biopsy specimen shows diffuse positivity for human placental lactogen (hPL) and Ki-67 index of 15%. Staging workup is negative for metastasis. What is the treatment of choice?", "options": ["Methotrexate and Folinic Acid", "Actinomycin D", "EMA-CO regimen", "Hysterectomy", "Pembrolizumab"], "answer": "D", "answer_index": 3, "explanation": "The diagnosis is Placental Site Trophoblastic Tumor (PSTT), distinguished from choriocarcinoma by low beta-hCG, strong hPL positivity, and origin from intermediate trophoblasts. Unlike choriocarcinoma, PSTT is relatively resistant to chemotherapy. For localized (Stage I) disease, hysterectomy is the primary and definitive treatment. Chemotherapy is reserved for metastatic or high-risk disease.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "D", "model_outputs": "To answer this question, I need to analyze the clinical presentation and diagnostic findings.\n\nThe patient has:\n- Amenorrhea 4 months post-delivery\n- 4 cm echogenic myometrial mass\n- Mildly elevated β-hCG (120 IU/L)\n- Immunohistochemistry positive for hPL\n- Elevated Ki-67 index (15%)\n- No metastasis\n\nThese findings are consistent with placental site trophoblastic tumor (PSTT), a rare form of gestational trophoblastic neoplasia. Key characteristics include:\n- Occurs after pregnancy (in this case, full-term delivery)\n- Produces low levels of hCG but is positive for hPL\n- Presents as a myometrial mass\n- Has intermediate proliferative activity (Ki-67)\n- Is relatively chemoresistant\n\nFor localized PSTT without metastasis, hysterectomy is the treatment of choice. This is because PSTT is less responsive to chemotherapy compared to other forms of gestational trophoblastic disease. Single-agent chemotherapy (options A and B) or multi-agent regimens like EMA-CO (option C) are typically reserved for metastatic disease or as adjuvant therapy. Immunotherapy with pembrolizumab (option E) is not standard treatment for PSTT.\n\nThe answer is (D)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-006", "question": "A 40-year-old male with a known diagnosis of Brugada syndrome presents to the ER in electrical storm, having received 4 appropriate ICD shocks for ventricular fibrillation in the past hour. He is currently conscious but anxious. Vital signs are BP 110/70, HR 90. Which pharmacologic agent is most appropriate to suppress the arrhythmia?", "options": ["Intravenous Amiodarone", "Intravenous Lidocaine", "Intravenous Isoproterenol", "Intravenous Procainamide", "Intravenous Metoprolol"], "answer": "C", "answer_index": 2, "explanation": "In Brugada syndrome electrical storm, the goal is to decrease the ST-segment elevation and dispersion. Isoproterenol (a beta-agonist) increases heart rate and calcium current, normalizing the ST segment and suppressing VF. Quinidine is the oral alternative. Amiodarone, beta-blockers, and sodium channel blockers (Procainamide, Lidocaine) are contraindicated or ineffective as they can unmask or exacerbate the Brugada pattern.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To answer this question, I need to consider the specific management of electrical storm in a patient with Brugada syndrome.\n\nBrugada syndrome is a channelopathy that affects sodium channels in the heart. In patients with Brugada syndrome experiencing electrical storm:\n\nA. Amiodarone - While commonly used for VF/VT, it can worsen Brugada ECG pattern and potentially exacerbate arrhythmias in these patients.\n\nB. Lidocaine - As a sodium channel blocker, it can worsen the sodium channel dysfunction in Brugada syndrome and is contraindicated.\n\nC. Isoproterenol - This is the preferred agent for electrical storm in Brugada syndrome. It increases heart rate and decreases the likelihood of phase 2 reentry that leads to ventricular arrhythmias in Brugada syndrome.\n\nD. Procainamide - As a sodium channel blocker, it can worsen Brugada syndrome and is contraindicated.\n\nE. Metoprolol - Beta-blockers are generally contraindicated in Brugada syndrome as they can unmask or worsen the ECG pattern and increase arrhythmia risk.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-007", "question": "A 32-year-old female presents with subacute confusion, bilateral hearing loss, and visual field deficits. MRI brain shows multiple T2 hyperintense lesions in the corpus callosum ('snowballs') and periventricular white matter. Fluorescein angiography reveals multiple branch retinal artery occlusions (BRAO). CSF shows mild pleocytosis and elevated protein but no oligoclonal bands. What is the most likely diagnosis?", "options": ["Multiple Sclerosis", "CADASIL", "Susac Syndrome", "Primary CNS Angiitis", "Mitochondrial Encephalomyopathy (MELAS)"], "answer": "C", "answer_index": 2, "explanation": "Susac Syndrome is a rare autoimmune endotheliopathy characterized by the clinical triad of encephalopathy, branch retinal artery occlusions (BRAO), and sensorineural hearing loss. The MRI finding of 'snowball' lesions in the corpus callosum is highly characteristic. It is often misdiagnosed as MS, but the presence of BRAO and callosal lesions (rather than callososeptal interface lesions) distinguishes it.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To determine the most likely diagnosis, I'll analyze the key clinical features and diagnostic findings presented.\n\nThe patient has:\n- Subacute confusion (encephalopathy)\n- Bilateral hearing loss\n- Visual field deficits\n- MRI showing \"snowball\" lesions in corpus callosum and periventricular white matter\n- Fluorescein angiography showing branch retinal artery occlusions (BRAO)\n- CSF with mild pleocytosis and elevated protein, but no oligoclonal bands\n\nAnalyzing each option:\n\nA. Multiple Sclerosis - While MS can cause white matter lesions, the absence of oligoclonal bands in CSF makes this less likely. MS typically doesn't cause hearing loss or BRAO.\n\nB. CADASIL - This is an inherited small vessel disease with subcortical infarcts and leukoencephalopathy. It typically presents with migraines, strokes, and dementia, not hearing loss or BRAO.\n\nC. Susac Syndrome - This is characterized by the clinical triad of encephalopathy, branch retinal artery occlusions, and hearing loss. The MRI findings of \"snowball\" lesions in the corpus callosum are highly characteristic of Susac syndrome.\n\nD. Primary CNS Angiitis - While this can cause encephalopathy and multiple infarcts, the specific combination of hearing loss and BRAO is not typical.\n\nE. MELAS - This typically presents with stroke-like episodes, seizures, and lactic acidosis. The MRI findings and BRAO are not characteristic.\n\nThe combination of encephalopathy, hearing loss, visual field deficits with BRAO, and characteristic corpus callosum lesions on MRI is classic for Susac syndrome, which is an autoimmune microangiopathy affecting the brain, retina, and inner ear.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-008", "question": "A 29-year-old male who has sex with men presents with severe proctitis, tenesmus, and rectal bleeding. Rectal swab NAAT is positive for *Chlamydia trachomatis*. He was treated with Doxycycline 100 mg BID for 7 days with no improvement. His partner recently returned from Europe. Which of the following is the most appropriate management?", "options": ["Repeat Doxycycline 100 mg BID for 7 days", "Azithromycin 1 g single dose", "Ceftriaxone 500 mg IM single dose", "Extend Doxycycline 100 mg BID to complete a 21-day course", "Moxifloxacin 400 mg daily for 14 days"], "answer": "D", "answer_index": 3, "explanation": "Severe proctitis in MSM with a positive Chlamydia test should raise suspicion for Lymphogranuloma Venereum (LGV), caused by L1, L2, or L3 serovars. LGV requires a prolonged course of doxycycline (21 days) compared to non-LGV chlamydia (7 days). Standard treatment failure and severe symptoms (bleeding/tenesmus) strongly support a diagnosis of LGV.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "D", "model_outputs": "To answer this question, I need to analyze the clinical scenario and determine the most appropriate management.\n\nThe patient is a 29-year-old MSM with:\n- Severe proctitis, tenesmus, and rectal bleeding\n- Positive rectal NAAT for Chlamydia trachomatis\n- Failed treatment with doxycycline 100 mg BID for 7 days\n- Partner recently returned from Europe\n\nThe key information here is that standard treatment for chlamydial proctitis (doxycycline for 7 days) failed. This suggests either:\n1. Poor adherence to treatment\n2. Reinfection\n3. Antimicrobial resistance\n4. Lymphogranuloma venereum (LGV), a more invasive form of C. trachomatis\n\nThe mention of the partner returning from Europe is significant because LGV is more common in Europe, particularly among MSM. LGV requires a longer treatment course than standard chlamydial infections.\n\nFor LGV proctitis, the recommended treatment is doxycycline 100 mg BID for 21 days, not just 7 days.\n\nRepeating the 7-day course or switching to azithromycin or ceftriaxone would be inadequate for LGV. Moxifloxacin is not the first-line treatment for suspected LGV.\n\nThe answer is (D)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-009", "question": "A 70-year-old man is evaluated for macrocytic anemia (MCV 105), thrombocytopenia, and recurrent inflammation of the ear and nose cartilage. He also has pulmonary infiltrates. Bone marrow biopsy demonstrates hypercellularity with vacuolization of myeloid and erythroid precursor cells. Genetic sequencing identifies a somatic mutation in *UBA1*. What is the diagnosis?", "options": ["Relapsing Polychondritis", "Myelodysplastic Syndrome (MDS)", "VEXAS Syndrome", "Sweet Syndrome", "Granulomatosis with Polyangiitis"], "answer": "C", "answer_index": 2, "explanation": "VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is a recently described disorder caused by somatic mutations in *UBA1*. It connects inflammatory features (polychondritis, vasculitis, infiltrates) with hematologic features (macrocytic anemia, vacuoles in marrow precursors). While it mimics relapsing polychondritis, the presence of marrow vacuoles and the *UBA1* mutation defines VEXAS.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To determine the diagnosis, I'll analyze the key clinical features and laboratory findings:\n\nKey findings:\n- 70-year-old man\n- Macrocytic anemia (MCV 105)\n- Thrombocytopenia\n- Recurrent inflammation of ear and nose cartilage\n- Pulmonary infiltrates\n- Hypercellular bone marrow with vacuolization of precursor cells\n- Somatic mutation in *UBA1* gene\n\nThe presence of a somatic mutation in the UBA1 gene is the most specific finding here. This mutation is the defining characteristic of VEXAS syndrome (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic syndrome). \n\nVEXAS syndrome typically presents in older men with:\n- Hematologic abnormalities (cytopenia, macrocytic anemia)\n- Inflammatory manifestations (including chondritis of ear/nose)\n- Pulmonary involvement\n- Characteristic bone marrow findings with vacuolization\n- UBA1 mutation\n\nWhile relapsing polychondritis shares the cartilage inflammation, it doesn't explain the UBA1 mutation or the specific bone marrow findings. MDS could explain some hematologic findings but not the specific UBA1 mutation or the inflammatory symptoms. Sweet syndrome and GPA don't match the complete clinical picture or the genetic finding.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-010", "question": "A 35-year-old female undergoes a cone biopsy for CIN 3. Pathology reveals invasive squamous cell carcinoma with 2 mm depth of invasion and 5 mm horizontal spread. Lymphovascular space invasion (LVSI) is extensively present. Margins are negative. Imaging shows no lymphadenopathy. She desires future fertility. According to NCCN guidelines, what is the recommended management?", "options": ["Simple trachelectomy", "Radical trachelectomy with pelvic lymph node assessment", "Conization with negative margins is sufficient", "Simple hysterectomy", "Pelvic radiation therapy"], "answer": "B", "answer_index": 1, "explanation": "The patient has Stage IA1 cervical cancer (invasion <= 3mm). However, the presence of Lymphovascular Space Invasion (LVSI) significantly increases the risk of lymph node metastasis and recurrence. Therefore, simple excision (cone) or simple trachelectomy/hysterectomy is insufficient. The recommended management for fertility preservation in IA1 with LVSI is radical trachelectomy with pelvic lymph node assessment (sentinel node or dissection).", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "To answer this question, I need to consider the NCCN guidelines for early-stage cervical cancer management, particularly for a patient with microinvasive disease who desires fertility preservation.\n\nThe key factors in this case are:\n- 35-year-old female who desires future fertility\n- Invasive squamous cell carcinoma\n- 2 mm depth of invasion (stage IA1)\n- 5 mm horizontal spread\n- Extensive lymphovascular space invasion (LVSI)\n- Negative margins\n- No lymphadenopathy on imaging\n\nFor stage IA1 cervical cancer (≤3 mm invasion), the presence of extensive LVSI is a critical factor that increases the risk of lymph node metastasis. According to NCCN guidelines, when LVSI is present in stage IA1 disease, pelvic lymph node assessment is recommended along with the primary treatment.\n\nFor patients desiring fertility preservation with stage IA1 with LVSI, radical trachelectomy (which preserves the uterine corpus while removing the cervix, upper vagina, and parametrial tissue) with pelvic lymph node assessment is the recommended approach. This provides adequate oncologic treatment while preserving fertility potential.\n\nSimple trachelectomy would be insufficient given the LVSI. Conization alone would be inadequate with LVSI present. Simple hysterectomy would eliminate fertility. Radiation therapy would be overly aggressive and also eliminate fertility.\n\nThe answer is (B)"}]